Detroit's mayor rejected a shipment of the Johnson & Johnson vaccine. Experts say that's nuts.
Experts feared the Johnson & Johnson vaccine's slightly lower efficacy rate would lead to an impression of a two-tiered system. That has been exactly the case in Detroit, where the mayor just rejected a shipment of the company's vaccine.
CNN reports that Detroit Mayor Mike Duggan (D) declined an allocation of the Johnson & Johnson COVID-19 vaccine this week, saying the other available vaccines are better. "Johnson & Johnson is a very good vaccine. Moderna and Pfizer are the best," he said. "And I am going to do everything I can to make sure the residents of the City of Detroit get the best." Stat News' Matthew Herper called this a "bad plan."
It's true that the Johnson & Johnson vaccine trials showed a 72 percent efficacy rate, while Moderna and Pfizer, the two other approved coronavirus vaccines, have a rate of about 95 percent. But health experts say it's still an excellent option, and has other perks like only requiring a single shot and frequently leading to fewer side effects, reports The New York Times. Dr. Anthony Fauci, the government's top infectious disease expert, said people shouldn't overthink which one to get, and explained the vaccines can't really be compared head-to-head because of different trial circumstances.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Besides, experts note, the raw numbers don't show the full picture. The Johnson & Johnson vaccine prevented all hospitalizations and deaths in its large clinical trial, meaning the slightly lower efficacy rate really only points to mild to moderate disease.
Detroit's mayor, however, said the city has been able to meet demand with just its supply of Pfizer and Moderna doses, but CNN notes Duggan's administration only expanded vaccine eligibility to residents ages 50 and older with chronic medical conditions on Thursday. Duggan said he would accept Johnson & Johnson doses later on if all other doses are distributed and there are remaining residents who want a vaccine.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Summer Meza has worked at The Week since 2018, serving as a staff writer, a news writer and currently the deputy editor. As a proud news generalist, she edits everything from political punditry and science news to personal finance advice and film reviews. Summer has previously written for Newsweek and the Seattle Post-Intelligencer, covering national politics, transportation and the cannabis industry.
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published